Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 57-64, January 2009

Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study

  • Laura Meléndez-Alafort

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 049 827 5342; fax: +39 049 827 5366.
  • ,
  • Anna Nadali

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
  • ,
  • Gianfranco Pasut

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
  • ,
  • Elena Zangoni

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
  • ,
  • Raffaele De Caro

      Affiliations

    • Department of Anatomy and Physiology, University of Padua, 35131 Padova, Italy
  • ,
  • Luca Cariolato

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
  • ,
  • Maria Cecilia Giron

      Affiliations

    • Department of Pharmacology and Anesthesiology, University of Padua, 35131 Padova, Italy
  • ,
  • Ignazio Castagliuolo

      Affiliations

    • Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, 35131 Padova, Italy
  • ,
  • Francesco M. Veronese

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy
  • ,
  • Ulderico Mazzi

      Affiliations

    • Department of Pharmaceutical Sciences, University of Padua, 35131 Padova, Italy

Received 9 July 2008; received in revised form 15 October 2008; accepted 25 October 2008.

Abstract 

The antimicrobial peptide ubiquicidin (UBI) directly labeled with technetium-99m (99mTc) has recently been shown to be specifically taken up at sites of infection; however, its chemical structure is not well defined. To address this problem, the aim of the present study was to label UBI using poly(ethyleneglycol)–N-(N-(3-diphenylphosphinopropionyl)glycyl)-S-tritylcysteine ligand (PEG-PN2S) in order to compare its ability to detect infection sites with that of 99mTc-UBI.

Methods

The PN2S-PEG-UBI conjugate was prepared and labeled with 99mTc, and its radiochemical purity was subsequently assessed. The stability of the conjugate to cysteine challenge and dilution with both saline solution and phosphate buffer was determined and serum stability and protein binding were also assessed. In vivo studies were carried out in healthy mice to study the biodistribution of 99mTc-PN2S-PEG-UBI and its precursor 99mTc-PN2S-PEG and in infected mice to compare the uptakes of 99mTc-UBI and 99mTc-PN2S-PEG-UBI at the site of infection using scintigraphic imaging and ex vivo tissue counting.

Results

99mTc-PN2S-PEG-UBI was obtained with high radiochemical purity (98±1%) and high stability. The amphiphilic nature of the conjugate leads to a tendency to form micellar aggregates that explain the high protein binding values obtained. Biodistribution studies in mice showed low renal clearance followed by a predominant reticuloendothelial system clearance that limits its application in the abdominal area. Statistical analysis revealed no significant difference between 99mTc-UBI and 99mTc-PN2S-PEG-UBI uptake in infected mouse thigh, and the site of infection was clearly visualized using scintigraphic imaging.

Conclusions

99mTc-PN2S-PEG-UBI proved to be as effective as 99mTc-UBI in detecting sites of infection; however, the well-defined chemical structure of 99mTc-PN2S-PEG-UBI makes it a better candidate for clinical imaging of infection.

Keywords: Ubiquicidin, Infection detection, Labeled peptides, PN2S, PEG, Technetium-99m

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(08)00235-7

doi:10.1016/j.nucmedbio.2008.10.011

Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 57-64, January 2009